Mark Yap
Mark Yap publishes mostly in Pulmonary and Respiratory Medicine, Hematology and Molecular Biology, on topics such as Chronic Lymphocytic Leukemia Research, Renal cell carcinoma treatment and Cancer Genomics and Diagnostics.
- World rank
- #5,599,619 of 7,710,434 ranked researchers
- Rank in United States
- #1,402,028 of 1,627,098
- Works
- 17
- Citations
- 122
- Citations per work
- 7.2
What does Mark Yap research?
Mark Yap's work is mostly in Medicine (48%), Biochemistry, Genetics and Molecular Biology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences848.0%
- Medicine848.0%
- Everything else743.7%
- Life Sciences18.3%
- 1Pulmonary and Respiratory Medicine21% of their works
- 2Hematology8% of their works
- 3Molecular Biology8% of their works
- 4Pathology and Forensic Medicine6% of their works
- 5Epidemiology6% of their works
- 6Genetics6% of their works
Research topics
Which keywords describe Mark Yap's research?
The keywords of their largest research topics: Prognostic Factors, Rituximab, Cancer Incidence, Chronic Lymphocytic Leukemia, Genomic Aberrations, Metastatic, Renal Cell Carcinoma and BCR-ABL.
- Nephrogenesis
- Multiple Primary Cancers
- Kidney Organoids
- Imatinib
- Classification
- BCR-ABL
- Metastatic
- Chronic Lymphocytic Leukemia
- Rituximab
- Prognostic Factors
- Cancer Incidence
- Genomic Aberrations
- Renal Cell Carcinoma
- Cancer Genomics
- Epstein-Barr Virus
- Kaposi's Sarcoma
- Lymphoma
- Mutational Signatures
- Second Primary Neoplasms
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Prognostic Factors62 topics
- Rituximab52 topics
- Cancer Incidence42 topics
- Chronic Lymphocytic Leukemia31 topic
- Genomic Aberrations31 topic
- Metastatic31 topic
- Renal Cell Carcinoma31 topic
- BCR-ABL21 topic
- Cancer Genomics21 topic
- Classification21 topic
- Epstein-Barr Virus21 topic
- Imatinib21 topic
- Kaposi's Sarcoma21 topic
- Kidney Organoids21 topic
- Lymphoma21 topic
- Multiple Primary Cancers21 topic
- Mutational Signatures21 topic
- Nephrogenesis21 topic
- Second Primary Neoplasms21 topic
Where does Mark Yap work?
Mark Yap's main affiliation in the publication record is McKesson (United States), United States.
How many publications and citations does Mark Yap have?
OpenAlex counts 17 works and 122 citations for Mark Yap, an h-index of 5, ranking #5,599,619 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mark Yap. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.